期刊文献+

25例Gilbert综合征患者临床及肝组织病理特点分析

Clinical and pathological features of 25 patients with Gilbert syndrome
下载PDF
导出
摘要 目的总结分析Gilbert综合征患者临床及肝组织病理特点。方法回顾性分析2006-2008年我院收治的25例Gilbert综合征患者的临床及肝脏病理资料。结果 25例患者中男性17例(68%),发病年龄18~30岁者15例(60%);合并HBV感染(4例)、药物性肝炎(2例)、酒精性肝炎(1例)等常见肝病7例(28%);多数病例临床症状轻微,17例(68%)表现为黄疸、疲乏,2例(8%)脾大。按照发病年龄分为<18岁组,18~30岁组,>30岁组,其总胆红素分别为121.4±27.9μmol/L、56.6±13.8μmol/L、60.7±28.1μmol/L,间接胆红素分别为87.9±35.4μmol/L、42.9±27.0μmol/L、42.0±31.6μmol/L,黄疸分布与发病年龄呈负相关(P<0.01)。光镜下,100%患者肝脏组织可见中央静脉周围肝细胞胞浆内棕褐色颗粒沉积。结论 Gilbert综合征青壮年男性多见,临床表现间接胆红素上升为主的黄疸,青少年发病可以表现为中重度黄疸;其肝脏病理可见中央静脉周围肝细胞胞浆内棕褐色颗粒沉积;常见肝病原因(如HBV感染,药物性/酒精性肝炎)合并Gilbert综合征值得临床重视。 Objectives To study the clinical and pathological features of Gilbert syndrome.Methods The clinical and pathological data of 25 patients with Gilbert syndrome were retrospectively analyzed.Results 17 cases(68%) were males.15 cases(60%) aged 18 to 30 years old,7 cases(29%) were complicated with other liver diseases(4 cases with hepatitis B,2 with drug-induced liver injury and 1 with alcoholic hepatitis).Most cases had mild symptoms,17 cases(68%) with jaundice and fatigue,2 cases(8%) with splenomegaly.The total bilirubin were 121.4±27.9μmol/L,56.6±13.8μmol/L,60.7±28.1μmol/L and the indirect bilirubin were 87.9±35.4μmol/L,42.9±27.0μmol/L,42.0±31.6μmol/L in patients aged less than 18 years,18 to 30 years and older than 30 years,respectively.The bilirubin had an inverse relation with age(P0.01).Dark brown granules around the central vein were observed under light microscope in all cases.Conclusions Gilbert syndrome was more commonly seen in young males and the indirect bilirubin elevated remarkably.The pathological examination revealed dark brown granules around the central vein.This disease is often complicated with hepatitis B,drug-induced liver injury and alcoholic hepatitis.
出处 《北京医学》 CAS 2010年第9期716-718,共3页 Beijing Medical Journal
关键词 GILBERT综合征 高间接胆红素血症 病理 Gilbert syndrome Indirect hyperbilirubinemia Pathology
  • 相关文献

参考文献8

  • 1Fevery J. Pathogenesis of Gilbert's syndrome. Eur J Clin Invest, 1981,11:417-418.
  • 2Teng HC, Huang MJ, Tang KS, et al. Combined UGT1A1 and UGT1A7 variant alleles are associated with increased risk of Gilberts syndrome in Taiwan Residents adults. Clin Genet,2007,72: 321-328.
  • 3Mackenzie PI, Walter Bock K, Burchell B, et al. Nomenclature update for the mammalian UDP glycosyhransferase (UGT) gene superfamily. Pharmacogenet Genomics,2005,15:677-685.
  • 4de Morais SM, Uetrecht JP, Wells PG. Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. Gastroenterology,1992,102:577-586.
  • 5Peter WH, Temorsche RH, Roelofs HM. Combined polymorphisms in UDP-gluouronosyltranl transferases IA1 and 1A6 : implications for patient with Gilbert syndrome. J Hepatol,2003,38:3-8.
  • 6Kay E, o'Dowd J, Thomas R, et al. Mild abnormalities in liver histology associated with chronic hepatitis: distinction from normal liver histology. J Clin Pathol,1997,50:929-931.
  • 7周福平,胡和平,于凤海,颜永壁,吴孟超.Gilbert综合征24例临床分析[J].临床内科杂志,2005,22(10):681-681. 被引量:12
  • 8余利红,高静,王春丽,王静,高艳,袁巧玲,孙志贤,王航雁,张成岗.一个中国Gilbert综合征家系的遗传学分析[J].遗传,2006,28(1):11-16. 被引量:17

二级参考文献12

  • 1Gilbert A, Lereboullet P. La cholemie simple familiale. Semaine Medicele, 1901, 21 : 241-243.
  • 2Clarke D J, Moghrabi N, Monaghan G, Cassidy A, Boxer M,Hume R, Burchell B. Genetic defects of the UDP glucuronosyltransferase-1 ( UGT1 ) gene that cause familial nonhaemolytic unconjugated hyperbilirubinaemias. Olin Ohim Acta, 1997, 266(1): 63-74.
  • 3Bosma P J, Ohowdhury d R, Bakker C, Gantla S, de Boer A,Oostra B A, lindhout D, Tytgat G N, Jansen P L, Oude Elferink R P, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltrasferase 1 in Gilberts syndrome. N Engl J Med, 1995, 333(18): 1171-1175.
  • 4Sampoetro M, Iolascon A. Molecular pathology of Crigler-Najjar type Ⅰand Ⅱ and Gilbert's syndromes. Haematologica,1999, 84(2): 150-157.
  • 5Raijmakers M T, Jansen P L, Steegers E A, Peters W H. Association of human liver bilirubin UDP-glucuronyltranseferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J Hepetol, 2000, 33(3): 348-351.
  • 6Monaghan G, Ryan M, Seddon R, Hume R, Burchell B. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet, 1996, 347(9001): 578-581.
  • 7lyanagi T, Emi Y, Ikushiro S. Biochemical and molecular aspects of genetic disorders of bilirubin metabolism. Biochim Biophys Acta, 1998, 1407(3): 173-184.
  • 8Koiwai O, Nishizawa M, Hasada K, Aono S, Adachi Y, Mamiya N, Sato H. Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase. Hum Mol Genet, 1995, 4(7) : 1183- 1186.
  • 9Yamamoto K, Sato H, Fujiyama Y, Doida Y, Bamba T. Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase ( UGT 1A 1 ) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type Ⅱ. Biochim Biophys Acta. 1998,1406(3) : 267-273.
  • 10Basu N K, Kole L, Owens IS. Evidence for phosphorylation requirement for human bilirubin UDP-glucuronosyltransferase( UGT1A 1 ) activity. Biochem Biophys Res Commun . 2003, 303(1): 98- 104.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部